49
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo

, , , , , , , , & show all
Pages 5703-5710 | Published online: 28 Nov 2017

References

  • DamronTAWardWGStewartAOsteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base ReportClin Orthop Relat Res2007459404717414166
  • FerrariSPalmeriniEAdjuvant and neoadjuvant combination chemotherapy for osteogenic sarcomaCurr Opin Oncol200719434134617545797
  • AndersonMEUpdate on Survival in OsteosarcomaOrthop Clin North Am201647128329226614941
  • FerrariSSerraMAn update on chemotherapy for osteosarcomaExpert Opin Pharmacother201516182727273626512909
  • RatanRPatelSRChemotherapy for soft tissue sarcomaCancer2016122192952296027434055
  • ShaikhABLiFLiMPresent advances and future perspectives of molecular targeted therapy for osteosarcomaInt J Mol Sci201617450627058531
  • NewmanDJCraggGMNatural products as sources of new drugs from 1981 to 2014J Nat Prod201679362966126852623
  • De SanctisRMarrariASantoroATrabectedin for the treatment of soft tissue sarcomasExpert Opin Pharmacother201617111569157727328277
  • AkihisaTTokudaHIchiishiEAnti-tumor promoting effects of multiflorane-type triterpenoids and cytotoxic activity of karounidiol against human cancer cell linesCancer Lett2001173191411578803
  • BannoNAkihisaTYasukawaKAnti-inflammatory activities of the triterpene acids from the resin of Boswellia carteriJ Ethnopharmacol2006107224925316621377
  • YanYYBaiJPXieYYuJZMaCGThe triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunctionOncol Lett20135124224823255929
  • ByunJYKimMJEumDYReactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cellsMol Pharmacol200976473474419574249
  • YangHLandis-PiwowarKRLuDPristimerin induces apoptosis by targeting the proteasome in prostate cancer cellsJ Cell Biochem2008103123424417541980
  • GaoXLiuYDeebDArbabASGautamSCAnticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-kappaB/mTOR signalingJ Exp Ther Oncol201410427528325509983
  • MuXShiWSunLLiHJiangZZhangLPristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activationMolecules20121766854686822669041
  • XieGYuXLiangHPristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signalingOncol Lett20161153111311627123073
  • MaSLiuXYaoYEffect of temozolomide on cell viability in gonadotroph adenoma cell linesOncol Rep201126354355021617871
  • MoriYTerauchiRShiraiTSuppression of heat shock protein 70 by siRNA enhances the antitumor effects of cisplatin in cultured human osteosarcoma cellsCell Stress Chaperones Epub201752
  • WuCCChanMLChenWYTsaiCYChangFRWuYCPristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondriaMol Cancer Ther2005481277128516093444
  • HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
  • DasariSTchounwouPBCisplatin in cancer therapy: molecular mechanisms of actionEur J Pharmacol201474036437825058905
  • DenaultJBSalvesenGSCaspases: keys in the ignition of cell deathChem Rev2002102124489450012475198
  • WongRSApoptosis in cancer: from pathogenesis to treatmentJ Exp Clin Cancer Res2011308721943236
  • PolivkaJJrJankuFMolecular targets for cancer therapy in the PI3K/AKT/mTOR pathwayPharmacol Ther2014142216417524333502
  • LiuPChengHRobertsTMZhaoJJTargeting the phosphoinositide 3-kinase pathway in cancerNat Rev Drug Discov20098862764419644473
  • BrownJSBanerjiUMaximising the potential of AKT inhibitors as anti-cancer treatmentsPharmacol Ther201717210111527919797
  • BrasierARThe NF-kappaB regulatory networkCardiovasc Toxicol20066211113017303919
  • CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
  • KarinMNuclear factor-kappaB in cancer development and progressionNature2006441709243143616724054
  • HussainARAhmedSOAhmedMCross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosisPLoS One201276e3994522768179
  • DeebDGaoXLiuYThe inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-κB/mTOR prosurvival signalingInt J Oncol20164931139114727573873
  • Eisenberg-LernerABialikSSimonHUKimchiALife and death partners: apoptosis, autophagy and the cross-talk between themCell Death Differ200916796697519325568
  • BurrisHA3rdOvercoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathwayCancer Chemother Pharmacol201371482984223377372
  • HeLWuYLinLHispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathwayCancer Sci2011102121922521087351
  • TangQLXieXBWangJGlycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcomaJ Natl Cancer Inst20121041074976322534782
  • YousefBAHassanHMGuerramMPristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cellsBiomed Pharmacother20167911211927044819
  • WangLNWangYLuYPristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivoJ Integr Med2014121203424461592
  • LuZJinYChenCLiJCaoQPanJPristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-AblMol Cancer2010911220482842